Loading…
Loading…
AMGN · NASDAQ · Healthcare
“With earnings of $14.33 supporting a $189B valuation, prudent investors must question whether this biotechnology enterprise offers adequate margin of safety at current levels.”
— In the voice of Graham
Track upcoming IPOs for the next three months. Filter by sector and expected valuation range.
Market Cap
$189.27B
P/E Ratio
24.54
Forward P/E
—
EPS
$14.33
PEG Ratio
0.22
Book Value
$16.09
Dividend Yield
2.71%
Profit Margin
20.98%
ROE
89.06%
Use the interactive ipo calendar with pre-loaded data for AMGEN Inc. Adjust discount rates, growth assumptions, and projection horizons to model different scenarios.
Pre-loaded inputs for AMGN: